Posted on Frankfurt am Main, Mörfelden-Walldorf

AMICI – Premium medical cannabis enabled by Cansativa

The Cansativa Group, Germany’s leading cannabis platform, is launching a new premium medical cannabis brand under the name “AMICI”. This new product line consists of the two products, „Strawberry Banana” and “Cherry Pie”, which have a high microbiological purity. All products of the brand “AMICI” are unirradiated. The cultivars derive from strictly EU-GMP controlled indoor cultivation facilities with many years of experience. The addition of “AMICI” to the product portfolio is another milestone and important step for Cansativa.

The premium product line is sold directly to pharmacies and selected wholesalers. In addition to the wholesale license, Cansativa has also had a manufacturer’s license for years and packs the goods in the usual pharmacy delivery quantity in their EU-GMP certified facility. This guarantees full control over the quality of the final product.

More Information about AMICI will follow on Nov 11th, 2022 under

Direct ordering (for professionals only):

“We are very pleased with the launch of AMICI, which will introduce two new medical cannabis strains on the German market. Patients will thus be given access to products from a new brand – a further step towards improving product diversity and security of supply on the German market. We want to give doctors, pharmacies and patients access to an extensive medical product portfolio and thus contribute to improving the quality of life with the help of medical cannabis,” says Managing Director and co-founder Benedikt Sons.


About Cansativa Group

Cansativa Group is the market leader in the medical cannabis market and sees itself as the driving force behind the young cannabis industry in Germany. Since the award of the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, they are the only company with approval for the distribution of medical cannabis from German cultivation. In the upcoming cannabis legalization, Cansativa Group sees itself as a pioneer in the democratization of the cannabis market.

Press Contact

Press release